Rithm Capital (RITM) shifts from mREIT to asset manager; FY25 ROE 19%, EPS beat +23%, 10.45% yield & discount to book. Read ...
Discover strategies to overcome sample preparation challenges in clinical proteomics, optimizing workflows for researchers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results